DK358284A - Insulin-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse til behandling af diabetes mellitus - Google Patents

Insulin-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse til behandling af diabetes mellitus Download PDF

Info

Publication number
DK358284A
DK358284A DK358284A DK358284A DK358284A DK 358284 A DK358284 A DK 358284A DK 358284 A DK358284 A DK 358284A DK 358284 A DK358284 A DK 358284A DK 358284 A DK358284 A DK 358284A
Authority
DK
Denmark
Prior art keywords
procedures
preparing
treatment
diabetes mellitus
insulin derivatives
Prior art date
Application number
DK358284A
Other languages
English (en)
Other versions
DK172211B1 (da
DK358284D0 (da
Inventor
Ulrich Grau
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK358284D0 publication Critical patent/DK358284D0/da
Publication of DK358284A publication Critical patent/DK358284A/da
Application granted granted Critical
Publication of DK172211B1 publication Critical patent/DK172211B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/622Insulins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues
DK358284A 1983-07-22 1984-07-20 Basisk modificeret insulin-derivat DK172211B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3326472 1983-07-22
DE19833326472 DE3326472A1 (de) 1983-07-22 1983-07-22 Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus

Publications (3)

Publication Number Publication Date
DK358284D0 DK358284D0 (da) 1984-07-20
DK358284A true DK358284A (da) 1985-01-23
DK172211B1 DK172211B1 (da) 1998-01-05

Family

ID=6204660

Family Applications (2)

Application Number Title Priority Date Filing Date
DK358284A DK172211B1 (da) 1983-07-22 1984-07-20 Basisk modificeret insulin-derivat
DK001790A DK172209B1 (da) 1983-07-22 1990-01-04 Lægemidler indeholdende basisk modificerede insulinderivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK001790A DK172209B1 (da) 1983-07-22 1990-01-04 Lægemidler indeholdende basisk modificerede insulinderivater

Country Status (20)

Country Link
US (1) US4701440A (da)
EP (1) EP0132770B1 (da)
JP (2) JPS6042397A (da)
AR (1) AR241864A1 (da)
AT (1) ATE29729T1 (da)
AU (1) AU569097B2 (da)
CA (1) CA1246548A (da)
DE (2) DE3326472A1 (da)
DK (2) DK172211B1 (da)
ES (2) ES8504678A1 (da)
FI (1) FI79854C (da)
GR (1) GR81551B (da)
HU (1) HUT37805A (da)
IE (1) IE57709B1 (da)
IL (1) IL72469A (da)
NO (1) NO167810C (da)
NZ (1) NZ208959A (da)
PH (1) PH23014A (da)
PT (1) PT78940A (da)
ZA (1) ZA845620B (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3327928A1 (de) * 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider
US4946828A (en) * 1985-03-12 1990-08-07 Novo Nordisk A/S Novel insulin peptides
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
DE3717370A1 (de) * 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
DE3827533A1 (de) * 1988-08-13 1990-02-15 Hoechst Ag Pharmazeutische zubereitung zur behandlung des diabetes mellitus
DE3837825A1 (de) * 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
HUT56857A (en) * 1988-12-23 1991-10-28 Novo Nordisk As Human insulin analogues
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
DE3936876A1 (de) * 1989-11-06 1991-05-23 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
AU9172991A (en) 1990-12-07 1992-07-08 Cnc Development, Inc. Catalytic chemical reactor
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin
ZA928916B (en) * 1991-11-26 1994-05-18 Lilly Co Eli Tri-arginine insulins
SG46640A1 (en) * 1991-11-29 1998-02-20 Hoechst Ag Peptides with an insulin like action
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
ATE264871T1 (de) 1996-07-26 2004-05-15 Aventis Pharma Gmbh Insulinderivate mit erhöhter zinkbindung
DE19649350A1 (de) * 1996-11-28 1998-06-04 Hoechst Ag Inositolglykane mit insulinartiger Wirkung
US6444641B1 (en) 1997-10-24 2002-09-03 Eli Lilly Company Fatty acid-acylated insulin analogs
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
WO2000075365A2 (en) 1999-06-08 2000-12-14 University Of Iowa Research Foundation Compounds and methods to enhance raav transduction
US6852694B2 (en) 2001-02-21 2005-02-08 Medtronic Minimed, Inc. Stabilized insulin formulations
DE60133490T2 (de) * 2001-02-21 2009-05-07 Seiwa Pro Co., Ltd., Matsubara Mittel zur entfernung von ablagerungen auf titanwerkstoff
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
EP1608763A2 (en) 2003-03-31 2005-12-28 University Of Iowa Research Foundation Compounds and methods to enhance raav transduction
EP2316844A3 (en) * 2003-05-21 2011-07-20 Biotech Tools S.A. Peptide complex
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
ES2650621T3 (es) 2008-10-17 2018-01-19 Sanofi-Aventis Deutschland Gmbh Combinación de una insulina y un agonista de GLP-1
TWI468171B (zh) 2009-11-13 2015-01-11 Sanofi Aventis Deutschland 含glp-1激動劑及甲硫胺酸之醫藥組成物
PE20121362A1 (es) 2009-11-13 2012-10-17 Sanofi Aventis Deutschland Composicion farmaceutica que comprende despro36exendina-4(1-39)-lys6-nh2, insulina gly(a21)-arg(b31)-arg(b32) y metionina
RU2546520C2 (ru) 2010-08-30 2015-04-10 Санофи-Авентис Дойчланд Гмбх Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN103917241A (zh) 2011-08-29 2014-07-09 赛诺菲-安万特德国有限公司 用于2型糖尿病患者中的血糖控制的药物组合
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
RS64300B1 (sr) 2014-12-12 2023-07-31 Sanofi Aventis Deutschland Formulacija fiksnog odnosa insulin glargina/liksisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
WO2017139381A1 (en) 2016-02-08 2017-08-17 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
MX2018010842A (es) 2016-03-07 2019-07-04 Univ Iowa Res Found Expresion mediada por el virus adeno-asociado (aav) usando un promotor y pontenciador sintetico.
US11541122B2 (en) 2018-09-19 2023-01-03 Ziylo Limited Glucose sensitive insulins and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2256215C3 (de) * 1972-11-16 1981-01-08 Hoechst Ag, 6000 Frankfurt Insulin-Zubereitung mit einem Gehalt an kristallinem Insulin und amorphem Desphenylalanin8' -insulin
DE2460753A1 (de) * 1974-12-21 1976-06-24 Hoechst Ag Verfahren zur herstellung von humaninsulin
NO153061C (no) * 1979-04-13 1986-01-08 Shionogi & Co Fremgangsmaate for fremstilling av et b30-threonininsulin
DK319780A (da) * 1980-07-24 1982-01-25 Forenede Bryggerier As Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen
NL8201650A (nl) * 1982-04-21 1983-11-16 Akzo Nv Semisynthetische bereiding van humane insuline.
DE3327928A1 (de) * 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DE3334407A1 (de) * 1983-09-23 1985-04-04 Hoechst Ag, 6230 Frankfurt In position b 30 modifizierte insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
JPH118546A (ja) * 1997-04-24 1999-01-12 Hitachi Ltd Cmos回路

Also Published As

Publication number Publication date
PH23014A (en) 1989-03-03
FI79854C (fi) 1990-03-12
EP0132770B1 (de) 1987-09-16
CA1246548A (en) 1988-12-13
JPH01294634A (ja) 1989-11-28
ES534487A0 (es) 1985-04-16
US4701440A (en) 1987-10-20
GR81551B (da) 1984-12-11
FI79854B (fi) 1989-11-30
IE57709B1 (en) 1993-03-10
IL72469A (en) 1989-07-31
NO842977L (no) 1985-01-23
EP0132770A1 (de) 1985-02-13
DK1790A (da) 1990-01-04
FI842914A (fi) 1985-01-23
JPS6042397A (ja) 1985-03-06
ATE29729T1 (de) 1987-10-15
FI842914A0 (fi) 1984-07-19
HUT37805A (en) 1986-02-28
DE3326472A1 (de) 1985-02-14
AU3092284A (en) 1985-01-24
ES8504678A1 (es) 1985-04-16
IE841889L (en) 1985-01-22
ZA845620B (en) 1985-02-27
NZ208959A (en) 1989-02-24
NO167810B (no) 1991-09-02
DE3466227D1 (en) 1987-10-22
DK172211B1 (da) 1998-01-05
ES535706A0 (es) 1985-06-01
AU569097B2 (en) 1988-01-21
ES8505646A1 (es) 1985-06-01
JPH052654B2 (da) 1993-01-13
DK172209B1 (da) 1998-01-05
PT78940A (de) 1984-08-01
IL72469A0 (en) 1984-11-30
AR241864A1 (es) 1993-01-29
JPH0357119B2 (da) 1991-08-30
DK1790D0 (da) 1990-01-04
NO167810C (no) 1991-12-18
DK358284D0 (da) 1984-07-20

Similar Documents

Publication Publication Date Title
DK358284D0 (da) Insulin-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse til behandling af diabetes mellitus
DK164595C (da) 3-methoxy-2-pyridyl-methylacrylater, fremgangsmaade til fremstilling deraf, middel indeholdende forbindelserne og disses eller midlets anvendelse til bekaempelse af svampe
DK349387A (da) Nitrofuranderivater samt fremgangsmaade til fremstilling deraf og anvendelse af forbindelserne som laegemiddel
DK143284A (da) Thiazolinderivater, deres fremstilling og anvendelse som laegemiddel
DK57480A (da) Fremgangsmaade til fremstilling af insulinderivater
DK166479C (da) Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning
DK19887D0 (da) Peptider med vasorelaxerende, natriuretisk og diuretisk virkning, fremgangsmaade til deres fremstiling, midler indeholdende forbindelserne og deres anvendelse
DK314188D0 (da) N-phenylpyrazolderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
DK106989A (da) Isoindolinonderivat, fremgangsmaade til fremstilling af dette, og laegemiddel indeholdende dette
DK353781A (da) Fremgangsmaade til fremstilling af insulinderivater
DK673988D0 (da) Manumycinderivater, fremgangsaader til deres fremstilling samt deres anvendelse
DK440288A (da) Anvendelse af eicosapentaensyre og/eller docosahexaensyre til fremstilling af midler til behandling af diabetes mellitus
DK530689A (da) Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse
DK76587A (da) Thioforbindelser med fungicid aktivitet, fremgangsmaade til deres fremstilling og deres anvendelse
DK73287A (da) Insulinderivater, deres fremstilling og anvendelse
DK604884A (da) Imidazoquinoliner indeholdende andre heterocycliske grupper, fremgangsmaader til fremstilling deraf samt deres anvendelse som laegemidler
DK382283D0 (da) Thiazol-derivater, fremgangsmade til fremstilling deraf samt deres anvendelse som laegemidler
NO890330D0 (no) Fremgangsmaate til fremstilling av forbindelser med psykotrop virkning.
DK586284D0 (da) Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
NO873727D0 (no) Fremgangsmaate for fremstilling av benzoxazoninforbindelser med terapeutisk aktivitet.
DK511782A (da) Benzylidenderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
DK380787A (da) Decahydro-2-naphthylalkylaminer, fremgangsmaade til deres fremstilling samt deres anvendelse
DK13680A (da) Sulfonerede insulinderivater samt fremgangsmaade til fremstilling deraf
DK96483A (da) Stabilt vandigt, terapeutisk insulinpraeparat, samt fremgangsmaade til fremstilling deraf
DK160832C (da) Heterocycliske bornan-derivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne forbindelser

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK